Welcome to LookChem.com Sign In|Join Free
  • or
L-Homoserine hydrochloride is a non-essential amino acid that serves as a crucial precursor to threonine and methionine. It is an important intermediate in the biosynthesis of essential compounds such as pantothenic acid and biotin. This chemical compound is widely used in the pharmaceutical industry for the production of various drugs and is a key component in the synthesis of certain antibiotics and other organic compounds. L-Homoserine hydrochloride has also been studied for its potential role in various biological processes and its applications in biotechnology and medicine.

196950-52-4

Post Buying Request

196950-52-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

196950-52-4 Usage

Uses

Used in Pharmaceutical Industry:
L-Homoserine hydrochloride is used as an intermediate in the synthesis of various pharmaceuticals for its role in the production of essential compounds and its potential applications in medicine.
Used in Antibiotic Synthesis:
L-Homoserine hydrochloride is used as a key component in the synthesis of certain antibiotics, contributing to the development of new antimicrobial agents.
Used in Organic Compound Synthesis:
L-Homoserine hydrochloride is used as a building block in the synthesis of other organic compounds, expanding its applications in the chemical industry.
Used in Biotechnology:
L-Homoserine hydrochloride is used as a potential agent in various biological processes, exploring its applications in biotechnology for enhancing biological functions and developing new technologies.
Used in Medical Research:
L-Homoserine hydrochloride is used in medical research to study its potential role in various biological processes and its applications in medicine, contributing to the advancement of medical knowledge and the development of new treatments.

Check Digit Verification of cas no

The CAS Registry Mumber 196950-52-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,6,9,5 and 0 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 196950-52:
(8*1)+(7*9)+(6*6)+(5*9)+(4*5)+(3*0)+(2*5)+(1*2)=184
184 % 10 = 4
So 196950-52-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H9NO3.ClH/c5-3(2-6)1-4(7)8;/h3,6H,1-2,5H2,(H,7,8);1H/t3-;/m1./s1

196950-52-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-amino-4-hydroxybutanoic acid,hydrochloride

1.2 Other means of identification

Product number -
Other names L-Homoserine hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:196950-52-4 SDS

196950-52-4Relevant academic research and scientific papers

Design and preparation of serine-threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 2. Synthesis of a functionalised nodularin macrocycle and a stripped-down microcystin macrocycle

Maude, Antony B.,Mehrotra, Amit P.,Gani, David

, p. 2513 - 2526 (2007/10/03)

Nodularins and microcystins are complex natural isopeptidic hepatotoxins that serve as subnanomolar inhibitors of the eukaryotic serine-threonine protein phosphatases, PP1 and PP2A. In Part 1 (A. P. Mehrotra, K. L. Webster and D. Gani, J. Chem. Soc., Perkin Trans. 1, 1997, preceding paper) each of the key structural or potentially reactive motifs within each macrocycle type was assessed as a contributor towards phosphatase inhibitory efficacy and a stripped-down nodularin-type macrocycle was identified as a suitable precursor to potentially active synthetic inhibitors. Subsequently, synthetic routes to the 19-membered nodularin macrocyclic system were developed, using solution-phase chemistry, which demonstrated that only certain cyclisation protocols were viable. Here we describe an extension of this chemistry to provide a 19-membered nodularin macrocycle, cyclo-[(3R)-3-hydroxymethyl-β-Ala-(R)-Glu-α-OMe-γ-Sar-(R)-Asp- α-OMe-β-(S)-Phe-], appropriately functionalised with a hydroxymethyl group for the incorporation of lipophilic side-chains. We also demonstrate that the 25-membered microcystin macrocycle, cyclo-[β-Ala-(R)-Glu-α-OMe-γ-Sar-(R)-Ala-(S)-Leu-(R)-Asp- α-OMe-β-(S)-Phe-], can be prepared in good yield using similar protocols in which macrocyclisation is effected through the reaction of the amino group of the (2S)-phenylalanine residue with the β-pentafluorophenyl ester of the (2R)-aspartic acid residue.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 196950-52-4